Stock Research: 10x Genomics

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

10x Genomics

NSQ:TXG US88025U1097
94
  • Value
    39
  • Growth
    83
  • Safety
    Safety
    88
  • Combined
    94
  • Sentiment
    55
  • 360° View
    360° View
    94
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

10x Genomics, Inc. is a life science technology company providing integrated solutions for single cell and spatial biology. Its main businesses include instruments, consumables, and software for Chromium and Visium platforms, supporting single cell gene expression, immune profiling, ATAC, and spatial gene expression. The company operates globally. In the last fiscal year, the company had a market cap of $1,533 million, profits of $415 million, revenue of $611 million, and 1,306 employees.

more
Index
NASDAQ
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
39 55 12 9
Growth
83 19 59 59
Safety
Safety
88 75 60 54
Sentiment
55 9 79 71
360° View
360° View
94 18 61 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
10 20 39 38
Opinions Change
73 6 50 50
Pro Holdings
n/a 8 65 69
Market Pulse
78 60 89 70
Sentiment
55 9 79 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
39 55 12 9
Growth
83 19 59 59
Safety Safety
88 75 60 54
Combined
94 44 40 28
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
52 61 11 9
Price vs. Earnings (P/E)
12 12 12 4
Price vs. Book (P/B)
46 53 12 6
Dividend Yield
1 1 1 1
Value
39 55 12 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
4 60 79 82
Profit Growth
82 36 21 91
Capital Growth
89 44 4 7
Stock Returns
81 7 91 33
Growth
83 19 59 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
100 100 100 100
Refinancing
61 63 33 31
Liquidity
1 1 12 7
Safety Safety
88 75 60 54

Similar Stocks

Discover high‑ranked alternatives to 10x Genomics and broaden your portfolio horizons.

Salesforce

NYQ:CRM
Country: USA
Industry: Application Software
Size: XX-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Walt Disney

NYQ:DIS
Country: USA
Industry: Movies & Entertainment
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NSQ:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: